反应详情

The assay for PMA/ionomycin-stimulated PBMC proliferation was performed in 96-well flat-bottomed microtitre plates. Compounds were prepared as 10 mM stock solutions in dimethyl sulfoxide. A 50-fold dilution of this was prepared in RPMI and serial dilutions were prepared from this solution. 10 μl of the 50-fold diluted stock, or dilutions of it, were added to the well to give concentrations in the assay starting at 9.5 μM and going down. Into each well was placed 1×105 PBMC, prepared from human peripheral blood from a single donor, in RPMI1640 medium supplemented with 10% human serum, 2 mM glutamine and penicillin/streptomycin. Phorbol myristate acetate (PMA) (0.5 ng/ml final concentration) and ionomycin (500 ng/ml final concentration) were added to these cells in supplemented RPMI1640 medium (as above) so that the final volume of the assay was 0.2 ml. The cells were incubated at 37° C. in a humidified atmosphere at 5% carbon dioxide for 72 hours. 3H-Thymidine (0.5 μCi) was added for the final 6 hours of the incubation. The level of radioactivity incorporated by the cells was then determined and this is a measure of proliferation.

1. customA 50-fold dilution of this was prepared in RPMI and serial dilutions
2. customwere prepared from this solution
3. addition10 μl of the 50-fold diluted stock, or dilutions of it, were added to the well
4. customto give
5. concentrationconcentrations in the assay
6. customprepared from human peripheral blood from a single donor, in RPMI1640 medium
7. concentrationPhorbol myristate acetate (PMA) (0.5 ng/ml final concentration) and ionomycin (500 ng/ml final
8. concentrationconcentration)
9. additionwere added to these cells in supplemented RPMI1640 medium (as above) so that the final volume of the assay
10. addition3H-Thymidine (0.5 μCi) was added for the final 6 hours of the incubation